No Data
KANGJI MEDICAL: Annual Report 2024
Hong Kong stocks fluctuate | KANGJI MEDICAL (09997) rises over 3%. Recently, its subsidiary Weijing Medical's four-arm surgical robot received registration approval.
KANGJI MEDICAL (09997) rose over 3%, as of the time of this report, up 2.64%, priced at 7.39 Hong Kong dollars, with a trading volume of 10.6246 million Hong Kong dollars.
Are Strong Financial Prospects The Force That Is Driving The Momentum In Kangji Medical Holdings Limited's HKG:9997) Stock?
Kangji Medical's Associate Gets China Nod for Laparoscopic Surgical Robot
Express News | Kangji Medical - Registration Approval for Four-Arm Surgical Robot of Weijing Medical From Nmpa
The industry is hotly discussing the future trends of nuclear medicine, will Hybrid NewCo become a new model for the RDC Industry to venture abroad? | Industry Observation
① Today, the 2025 Future XDC New Drug Conference is held in Chengdu; ② Executives from companies such as Baillie Tianheng and Kelun Botai, along with numerous experts and scholars in the industry, will jointly discuss cutting-edge technologies in ADC/nuclear drug development, overseas strategies, and other Topics.
Getting In Cheap On Kangji Medical Holdings Limited (HKG:9997) Is Unlikely